SCHEMBL280145

SCHEMBL280145

CC(C)[C@@H](C=O)NC(=O)[C@]1(C)CCC[C@@]2(C)C3=CCC[C@](C)(I)C3CCC12

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 6/20 0.38
▸ NR1H3 Q13133 6/20 0.35
▸ NR1H2 P55055 5/20 0.35
▸ PTPN1 P18031 1/20 0.35
▸ MEN1 O00255 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ RXRA P19793 1/20 0.31
▸ CCNE1 P24864 1/20 0.31
▸ CDK2 P24941 1/20 0.31
▸ RXRB P28702 1/20 0.31
▸ RXRG P48443 1/20 0.31
▸ KARS1 Q15046 1/20 0.31
▸ POLA1 P09884 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL280416 0.90 PTGS1 (0.39) PTGS1NR1H3NR1H2PTPN1MEN1
SCHEMBL12522438 0.88 PTGS1 (0.39) PTGS1NR1H3NR1H2PTPN1MEN1
SCHEMBL280417 0.85 PTGS1 (0.37) PTGS1NR1H3NR1H2PTPN1
SCHEMBL12887742 0.85 PTGS1 (0.38) PTGS1NR1H3NR1H2PTPN1RXRA
SCHEMBL280336 0.79 PTGS1 (0.53) PTGS1NR1H3NR1H2PTPN1
SCHEMBL280188 0.79 SOD1 (0.47) PTGS1NR1H3NR1H2PTPN1MEN1
SCHEMBL280154 0.79 SOD1 (0.47) PTGS1NR1H3NR1H2PTPN1MEN1
SCHEMBL10225176 0.79 SOD1 (0.47) PTGS1NR1H3NR1H2PTPN1MEN1
SCHEMBL280147 0.78 NR1H3 (0.44) PTGS1NR1H3NR1H2PTPN1RXRA
SCHEMBL280289 0.73 KARS1 (0.39) PTGS1NR1H3PTPN1MEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8133915-B2 Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators NEREUS PHARMACEUTICALS, INC. (US) 2012-03-13 — — US disclosed
Send feedback